Author: <span>Mesothelioma News</span>

Peritoneal Cancer Therapeutics Pipeline Review H1 2015 Market Research Report

The report ” Peritoneal Cancer – Pipeline Review, H1 2015 ” provides comprehensive information on the therapeutic development for peritoneal cancer . Primary peritoneal cancer is a relatively rare cancer that develops most commonly in women.

Polaris Group Announces Treatment Of First Patient In Phase 1 Study …

In addition to a global Phase 3 study in hepatocellular carcinoma featuring ADI-PEG 20 as a monotherapy, Polaris Group is currently conducting clinical trials on ADI-PEG 20 in combination with cisplatin in melanoma and ovarian cancer, in combination wi…

Discoveries suggest that asbestos may be more widespread in Nevada, Arizona

In 2011, geologists at the University of Nevada, Las Vegas, began discovering asbestos where none should be — in granite rocks with a geologic history not previously known to produce asbestos. The discoveries, in Clark County in southern Nevada and ac…

Weitz & Luxenberg PC Announces Sheldon Silver Taking Leave of Absence

Summary: Embattled New York Assembly Speaker Sheldon Silver has announced that he is taking a leave of absence from Weitz & Luxenberg PC. Sheldon Silver , the New York Assembly Speaker, will take a leave of absence from his personal injury law firm…

Wake Up Call: Snowball fights, a new Greek government, and risky apps

Good morning, Columbia! We hope you’re keeping safe and toasty today. Now that classes are cancelled and your only appointment for the day is throwing a snowball at Alma, why not cuddle up against a radiator to read this morning’s Wake Up Call? Ferris …

Wake Up Call: Snowball fights, a new Greek government, and risky apps

Good morning, Columbia! We hope you’re keeping safe and toasty today. Now that classes are cancelled and your only appointment for the day is throwing a snowball at Alma, why not cuddle up against a radiator to read this morning’s Wake Up Call? Ferris …

Now Available: Morphotek, Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

The company discovers and develops biological-based products for the treatment of cancer, inflammatory disease and infectious diseases. Its product pipeline includes farletuzumab , amatuximab , MORAb-004, MORAb-022, MORAb-048, MORAb-050 and MORAb-066.